Serum insulin-like growth factor 1 in congenital heart disease

Archives of Disease in Childhood

Volumn 75, Issue 2, 1996, Pages 162-163

  Barton, J S ^a,b   Hindmarsh, P C ^a   Preece, M A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Congenital heart disease; Insulin like growth factor binding protein 3; Insulin like growth factor I

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0029817936     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.2.162     Document Type: Article

References (6)

1. Mehrizi A, Drash A. Growth disturbance in congenital heart disease. J Pediatr 1962;61:418-29.
2. Barton JS, Hindmarsh PC, Scrimgeour CM, Rennie MJ, Preece MA. Energy expenditure in congenital heart disease. Arch Dis Child 1994;70:5-9.
3. Zapf J, Schmid CH, Froesch ER. Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 1984;13:3-30.
4. Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Res 1994; 42:140-4.
5. Ikkos DD, Thanopoulos V, Ikkos DG. 24 h plasma levels of growth hormone in growth retardation of children with congenital heart disease. Helv Paediatr Acta 1974; 29:583-8.
6. Bernstein D, Jasper JR, Rosenfeld RG, Hintz RL. Decreased serum insulin-like growth factor I associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest 1992;89:1128-32.